Table 1. Melanoma Patient Characteristics of the Overall Survival (OS) Cohort.

Clinical Characteristics
Gender
Male, no. (%)	75 (72.1)
Female, no. (%)	29 (27.9)
Age
Median, no. (range)	74.5 (22-96)
Location of Tumor
Trunk, no. (%)	61 (58.7)
Extremity, no. (%)	41 (39.4)
Unknown, no. (%)	2 (1.9)
Stage
II, no. (%)	91 (87.5)
III, no. (%)	13 (12.5)
Pathological Characteristics
Depth (mm)
Median, no. (range)	2.5 (0.6-26)
Ulceration
Absent, no. (%)	36 (34.6)
Present, no. (%)	65 (62.5)
Unknown, no. (%)	3 (2.9)
TILs
Absent, no. (%)	2 (1.9)
Non-Brisk, no. (%)	59 (56.8)
Brisk, no. (%)	33 (31.7)
Unknown, no. (%)	10 (9.6)
Outcome Characteristics
Patient Follow Up (months)
Median, no. (range)	45 (4-173)
OS (months)
Alive (at least 2 years), no. (%)	31 (29.8)
Dead, no. (%)	73 (70.2)
DSS (months)
Alive or NED at Death, no. (%)	42 (40.4)
Dead with melanoma, no. (%)	22 (21.2)
Unknown, no. (%)	40 (38.4)

(TILs = Tumor Infiltrating Lymphocytes, OS = Overall Survival, DSS = Disease Specific Survival, NED = No Evidence of Disease)